# Duloxetine Versus Placebo for Fibromyalgia

> **NCT00489073** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 345 (—)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** duloxetine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00489073
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 345 (—)
- **Last updated:** 2007-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489073, "Duloxetine Versus Placebo for Fibromyalgia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00489073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*